Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03709680 |
|
Recruitment Status :
Active, not recruiting
First Posted : October 17, 2018
Last Update Posted : March 26, 2024
|
Sponsor:
Pfizer
Collaborator:
Children's Oncology Group (COG)
Information provided by (Responsible Party):
Pfizer
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | June 24, 2024 |
| Estimated Study Completion Date : | February 25, 2025 |